Skip to main content
Top
Published in: Molecular Cancer 1/2008

Open Access 01-12-2008 | Research

Transcription analysis in the MeLiM swine model identifies RACK1 as a potential marker of malignancy for human melanocytic proliferation

Authors: Giorgia Egidy, Sophia Julé, Philippe Bossé, Florence Bernex, Claudine Geffrotin, Silvia Vincent-Naulleau, Vratislav Horak, Xavier Sastre-Garau, Jean-Jacques Panthier

Published in: Molecular Cancer | Issue 1/2008

Login to get access

Abstract

Background

Metastatic melanoma is a severe disease. Few experimental animal models of metastatic melanoma exist. MeLiM minipigs exhibit spontaneous melanoma. Cutaneous and metastatic lesions are histologically similar to human's. However, most of them eventually spontaneously regress. Our purpose was to investigate whether the MeLiM model could reveal markers of malignancy in human melanocytic proliferations.

Results

We compared the serial analysis of gene expression (SAGE) between normal pig skin melanocytes and melanoma cells from an early pulmonary metastasis of MeLiM minipigs. Tag identification revealed 55 regulated genes, including GNB2L1 which was found upregulated in the melanoma library. In situ hybridisation confirmed GNB2L1 overexpression in MeLiM melanocytic lesions. GNB2L1 encodes the adaptor protein RACK1, recently shown to influence melanoma cell lines tumorigenicity. We studied the expression of RACK1 by immunofluorescence and confocal microscopy in tissues specimens of normal skin, in cutaneous and metastatic melanoma developped in MeLiM minipigs and in human patients. In pig and human samples, the results were similar. RACK1 protein was not detected in normal epidermal melanocytes. By contrast, RACK1 signal was highly increased in the cytoplasm of all melanocytic cells of superficial spreading melanoma, recurrent dermal lesions and metastatic melanoma. RACK1 partially colocalised with activated PKCαβ. In pig metastases, additional nuclear RACK1 did not associate to BDNF expression. In human nevi, the RACK1 signal was low.

Conclusion

RACK1 overexpression detected in situ in human melanoma specimens characterized cutaneous and metastatic melanoma raising the possibility that RACK1 can be a potential marker of malignancy in human melanoma. The MeLiM strain provides a relevant model for exploring mechanisms of melanocytic malignant transformation in humans. This study may contribute to a better understanding of melanoma pathophysiology and to progress in diagnosis.
Appendix
Available only for authorised users
Literature
1.
go back to reference Vincent-Naulleau S, Le Chalony C, Leplat JJ, Bouet S, Bailly C, Spatz A, Vielh P, Avril MF, Tricaud Y, Gruand J: Clinical and histopathological characterization of cutaneous melanomas in the melanoblastoma-bearing Libechov minipig model. Pigment Cell Res. 2004, 17: 24-35.CrossRefPubMed Vincent-Naulleau S, Le Chalony C, Leplat JJ, Bouet S, Bailly C, Spatz A, Vielh P, Avril MF, Tricaud Y, Gruand J: Clinical and histopathological characterization of cutaneous melanomas in the melanoblastoma-bearing Libechov minipig model. Pigment Cell Res. 2004, 17: 24-35.CrossRefPubMed
2.
go back to reference Geffrotin C, Crechet F, Le Roy P, Le Chalony C, Leplat JJ, Iannuccelli N, Barbosa A, Renard C, Gruand J, Milan D: Identification of five chromosomal regions involved in predisposition to melanoma by genome-wide scan in the MeLiM swine model. Int J Cancer. 2004, 110: 39-50.CrossRefPubMed Geffrotin C, Crechet F, Le Roy P, Le Chalony C, Leplat JJ, Iannuccelli N, Barbosa A, Renard C, Gruand J, Milan D: Identification of five chromosomal regions involved in predisposition to melanoma by genome-wide scan in the MeLiM swine model. Int J Cancer. 2004, 110: 39-50.CrossRefPubMed
3.
go back to reference Du ZQ, Vincent-Naulleau S, Gilbert H, Vignoles F, Crechet F, Shimogiri T, Yasue H, Leplat JJ, Bouet S, Gruand J: Detection of novel quantitative trait loci for cutaneous melanoma by genome-wide scan in the MeLiM swine model. Int J Cancer. 2007, 120: 303-320.CrossRefPubMed Du ZQ, Vincent-Naulleau S, Gilbert H, Vignoles F, Crechet F, Shimogiri T, Yasue H, Leplat JJ, Bouet S, Gruand J: Detection of novel quantitative trait loci for cutaneous melanoma by genome-wide scan in the MeLiM swine model. Int J Cancer. 2007, 120: 303-320.CrossRefPubMed
4.
go back to reference Le Chalony C, Renard C, Vincent-Naulleau S, Crechet F, Leplat JJ, Tricaud Y, Horak V, Gruand J, Le Roy P, Frelat G, Geffrotin C: CDKN2A region polymorphism and genetic susceptibility to melanoma in the melim swine model of familial melanoma. Int J Cancer. 2003, 103: 631-635.CrossRefPubMed Le Chalony C, Renard C, Vincent-Naulleau S, Crechet F, Leplat JJ, Tricaud Y, Horak V, Gruand J, Le Roy P, Frelat G, Geffrotin C: CDKN2A region polymorphism and genetic susceptibility to melanoma in the melim swine model of familial melanoma. Int J Cancer. 2003, 103: 631-635.CrossRefPubMed
5.
go back to reference Horak V, Fortyn K, Hruban V, Klaudy J: Hereditary melanoblastoma in miniature pigs and its successful therapy by devitalization technique. Cell Mol Biol (Noisy-le-grand). 1999, 45: 1119-1129. Horak V, Fortyn K, Hruban V, Klaudy J: Hereditary melanoblastoma in miniature pigs and its successful therapy by devitalization technique. Cell Mol Biol (Noisy-le-grand). 1999, 45: 1119-1129.
6.
go back to reference Velculescu VE, Zhang L, Vogelstein B, Kinzler KW: Serial analysis of gene expression. Science. 1995, 270: 484-487.CrossRefPubMed Velculescu VE, Zhang L, Vogelstein B, Kinzler KW: Serial analysis of gene expression. Science. 1995, 270: 484-487.CrossRefPubMed
7.
go back to reference Jule S, Bosse P, Egidy G, Panthier JJ: Establishment and characterization of a normal melanocyte cell line derived from pig skin. Pigment Cell Res. 2003, 16: 407-410.CrossRefPubMed Jule S, Bosse P, Egidy G, Panthier JJ: Establishment and characterization of a normal melanocyte cell line derived from pig skin. Pigment Cell Res. 2003, 16: 407-410.CrossRefPubMed
9.
go back to reference Pogue-Geile K, Geiser JR, Shu M, Miller C, Wool IG, Meisler AI, Pipas JM: Ribosomal protein genes are overexpressed in colorectal cancer: isolation of a cDNA clone encoding the human S3 ribosomal protein. Mol Cell Biol. 1991, 11: 3842-3849.PubMedCentralPubMed Pogue-Geile K, Geiser JR, Shu M, Miller C, Wool IG, Meisler AI, Pipas JM: Ribosomal protein genes are overexpressed in colorectal cancer: isolation of a cDNA clone encoding the human S3 ribosomal protein. Mol Cell Biol. 1991, 11: 3842-3849.PubMedCentralPubMed
10.
go back to reference Suda T, Tsunoda T, Uchida N, Watanabe T, Hasegawa S, Satoh S, Ohgi S, Furukawa Y, Nakamura Y, Tahara H: Identification of secernin 1 as a novel immunotherapy target for gastric cancer using the expression profiles of cDNA microarray. Cancer Sci. 2006, 97: 411-419.CrossRefPubMed Suda T, Tsunoda T, Uchida N, Watanabe T, Hasegawa S, Satoh S, Ohgi S, Furukawa Y, Nakamura Y, Tahara H: Identification of secernin 1 as a novel immunotherapy target for gastric cancer using the expression profiles of cDNA microarray. Cancer Sci. 2006, 97: 411-419.CrossRefPubMed
11.
go back to reference Nishiu M, Yanagawa R, Nakatsuka S, Yao M, Tsunoda T, Nakamura Y, Aozasa K: Microarray analysis of gene-expression profiles in diffuse large B-cell lymphoma: identification of genes related to disease progression. Jpn J Cancer Res. 2002, 93: 894-901.CrossRefPubMed Nishiu M, Yanagawa R, Nakatsuka S, Yao M, Tsunoda T, Nakamura Y, Aozasa K: Microarray analysis of gene-expression profiles in diffuse large B-cell lymphoma: identification of genes related to disease progression. Jpn J Cancer Res. 2002, 93: 894-901.CrossRefPubMed
12.
go back to reference Dmitrenko V, Shostak K, Boyko O, Khomenko O, Rozumenko V, Malisheva T, Shamayev M, Zozulya Y, Kavsan V: Reduction of the transcription level of the mitochondrial genome in human glioblastoma. Cancer Lett. 2005, 218: 99-107.CrossRefPubMed Dmitrenko V, Shostak K, Boyko O, Khomenko O, Rozumenko V, Malisheva T, Shamayev M, Zozulya Y, Kavsan V: Reduction of the transcription level of the mitochondrial genome in human glioblastoma. Cancer Lett. 2005, 218: 99-107.CrossRefPubMed
13.
go back to reference Berns H, Humar R, Hengerer B, Kiefer FN, Battegay EJ: RACK1 is up-regulated in angiogenesis and human carcinomas. Faseb J. 2000, 14: 2549-2558.CrossRefPubMed Berns H, Humar R, Hengerer B, Kiefer FN, Battegay EJ: RACK1 is up-regulated in angiogenesis and human carcinomas. Faseb J. 2000, 14: 2549-2558.CrossRefPubMed
14.
go back to reference Ron D, Vagts AJ, Dohrman DP, Yaka R, Jiang Z, Yao L, Crabbe J, Grisel JE, Diamond I: Uncoupling of betaIIPKC from its targeting protein RACK1 in response to ethanol in cultured cells and mouse brain. Faseb J. 2000, 14: 2303-2314.CrossRefPubMed Ron D, Vagts AJ, Dohrman DP, Yaka R, Jiang Z, Yao L, Crabbe J, Grisel JE, Diamond I: Uncoupling of betaIIPKC from its targeting protein RACK1 in response to ethanol in cultured cells and mouse brain. Faseb J. 2000, 14: 2303-2314.CrossRefPubMed
15.
go back to reference McGough NN, He DY, Logrip ML, Jeanblanc J, Phamluong K, Luong K, Kharazia V, Janak PH, Ron D: RACK1 and brain-derived neurotrophic factor: a homeostatic pathway that regulates alcohol addiction. J Neurosci. 2004, 24: 10542-10552.CrossRefPubMed McGough NN, He DY, Logrip ML, Jeanblanc J, Phamluong K, Luong K, Kharazia V, Janak PH, Ron D: RACK1 and brain-derived neurotrophic factor: a homeostatic pathway that regulates alcohol addiction. J Neurosci. 2004, 24: 10542-10552.CrossRefPubMed
16.
go back to reference Innominato PF, Libbrecht L, Oord van den JJ: Expression of neurotrophins and their receptors in pigment cell lesions of the skin. J Pathol. 2001, 194: 95-100.CrossRefPubMed Innominato PF, Libbrecht L, Oord van den JJ: Expression of neurotrophins and their receptors in pigment cell lesions of the skin. J Pathol. 2001, 194: 95-100.CrossRefPubMed
17.
go back to reference King R, Weilbaecher KN, McGill G, Cooley E, Mihm M, Fisher DE: Microphthalmia transcription factor. A sensitive and specific melanocyte marker for MelanomaDiagnosis. Am J Pathol. 1999, 155: 731-738.PubMedCentralCrossRefPubMed King R, Weilbaecher KN, McGill G, Cooley E, Mihm M, Fisher DE: Microphthalmia transcription factor. A sensitive and specific melanocyte marker for MelanomaDiagnosis. Am J Pathol. 1999, 155: 731-738.PubMedCentralCrossRefPubMed
18.
go back to reference Chin L: The genetics of malignant melanoma: lessons from mouse and man. Nat Rev Cancer. 2003, 3: 559-570.CrossRefPubMed Chin L: The genetics of malignant melanoma: lessons from mouse and man. Nat Rev Cancer. 2003, 3: 559-570.CrossRefPubMed
19.
go back to reference Noonan FP, Recio JA, Takayama H, Duray P, Anver MR, Rush WL, De Fabo EC, Merlino G: Neonatal sunburn and melanoma in mice. Nature. 2001, 413: 271-272.CrossRefPubMed Noonan FP, Recio JA, Takayama H, Duray P, Anver MR, Rush WL, De Fabo EC, Merlino G: Neonatal sunburn and melanoma in mice. Nature. 2001, 413: 271-272.CrossRefPubMed
20.
go back to reference Clark EA, Golub TR, Lander ES, Hynes RO: Genomic analysis of metastasis reveals an essential role for RhoC. Nature. 2000, 406: 532-535.CrossRefPubMed Clark EA, Golub TR, Lander ES, Hynes RO: Genomic analysis of metastasis reveals an essential role for RhoC. Nature. 2000, 406: 532-535.CrossRefPubMed
21.
go back to reference Weeraratna AT, Jiang Y, Hostetter G, Rosenblatt K, Duray P, Bittner M, Trent JM: Wnt5a signaling directly affects cell motility and invasion of metastatic melanoma. Cancer Cell. 2002, 1: 279-288.CrossRefPubMed Weeraratna AT, Jiang Y, Hostetter G, Rosenblatt K, Duray P, Bittner M, Trent JM: Wnt5a signaling directly affects cell motility and invasion of metastatic melanoma. Cancer Cell. 2002, 1: 279-288.CrossRefPubMed
22.
go back to reference Hoek K, Rimm DL, Williams KR, Zhao H, Ariyan S, Lin A, Kluger HM, Berger AJ, Cheng E, Trombetta ES: Expression profiling reveals novel pathways in the transformation of melanocytes to melanomas. Cancer Res. 2004, 64: 5270-5282.CrossRefPubMed Hoek K, Rimm DL, Williams KR, Zhao H, Ariyan S, Lin A, Kluger HM, Berger AJ, Cheng E, Trombetta ES: Expression profiling reveals novel pathways in the transformation of melanocytes to melanomas. Cancer Res. 2004, 64: 5270-5282.CrossRefPubMed
23.
go back to reference Moschos SJ, Smith AP, Mandic M, Athanassiou C, Watson-Hurst K, Jukic DM, Edington HD, Kirkwood JM, Becker D: SAGE and antibody array analysis of melanoma-infiltrated lymph nodes: identification of Ubc9 as an important molecule in advanced-stage melanomas. Oncogene. 2007, 26: 4216-4225.CrossRefPubMed Moschos SJ, Smith AP, Mandic M, Athanassiou C, Watson-Hurst K, Jukic DM, Edington HD, Kirkwood JM, Becker D: SAGE and antibody array analysis of melanoma-infiltrated lymph nodes: identification of Ubc9 as an important molecule in advanced-stage melanomas. Oncogene. 2007, 26: 4216-4225.CrossRefPubMed
24.
go back to reference Weeraratna AT, Becker D, Carr KM, Duray PH, Rosenblatt KP, Yang S, Chen Y, Bittner M, Strausberg RL, Riggins GJ: Generation and analysis of melanoma SAGE libraries: SAGE advice on the melanoma transcriptome. Oncogene. 2004, 23: 2264-2274.CrossRefPubMed Weeraratna AT, Becker D, Carr KM, Duray PH, Rosenblatt KP, Yang S, Chen Y, Bittner M, Strausberg RL, Riggins GJ: Generation and analysis of melanoma SAGE libraries: SAGE advice on the melanoma transcriptome. Oncogene. 2004, 23: 2264-2274.CrossRefPubMed
25.
go back to reference Park HY, Wu H, Killoran CE, Gilchrest BA: The receptor for activated C-kinase-I (RACK-I) anchors activated PKC-beta on melanosomes. J Cell Sci. 2004, 117: 3659-3668.CrossRefPubMed Park HY, Wu H, Killoran CE, Gilchrest BA: The receptor for activated C-kinase-I (RACK-I) anchors activated PKC-beta on melanosomes. J Cell Sci. 2004, 117: 3659-3668.CrossRefPubMed
26.
go back to reference Lopez-Bergami P, Huang C, Goydos JS, Yip D, Bar-Eli M, Herlyn M, Smalley KS, Mahale A, Eroshkin A, Aaronson S, Ronai Z: Rewired ERK-JNK signaling pathways in melanoma. Cancer Cell. 2007, 11: 447-460.PubMedCentralCrossRefPubMed Lopez-Bergami P, Huang C, Goydos JS, Yip D, Bar-Eli M, Herlyn M, Smalley KS, Mahale A, Eroshkin A, Aaronson S, Ronai Z: Rewired ERK-JNK signaling pathways in melanoma. Cancer Cell. 2007, 11: 447-460.PubMedCentralCrossRefPubMed
27.
go back to reference Lee JT, Herlyn M: Microenvironmental influences in melanoma progression. J Cell Biochem. 2007, 101: 862-872.CrossRefPubMed Lee JT, Herlyn M: Microenvironmental influences in melanoma progression. J Cell Biochem. 2007, 101: 862-872.CrossRefPubMed
28.
go back to reference Chou YC, Chou CC, Chen YK, Tsai S, Hsieh FM, Liu HJ, Hseu TH: Structure and genomic organization of porcine RACK1 gene. Biochim Biophys Acta. 1999, 1489: 315-322.CrossRefPubMed Chou YC, Chou CC, Chen YK, Tsai S, Hsieh FM, Liu HJ, Hseu TH: Structure and genomic organization of porcine RACK1 gene. Biochim Biophys Acta. 1999, 1489: 315-322.CrossRefPubMed
29.
go back to reference Mochly-Rosen D, Khaner H, Lopez J: Identification of intracellular receptor proteins for activated protein kinase C. Proc Natl Acad Sci USA. 1991, 88: 3997-4000.PubMedCentralCrossRefPubMed Mochly-Rosen D, Khaner H, Lopez J: Identification of intracellular receptor proteins for activated protein kinase C. Proc Natl Acad Sci USA. 1991, 88: 3997-4000.PubMedCentralCrossRefPubMed
30.
go back to reference Chang BY, Conroy KB, Machleder EM, Cartwright CA: RACK1, a receptor for activated C kinase and a homolog of the beta subunit of G proteins, inhibits activity of src tyrosine kinases and growth of NIH 3T3 cells. Mol Cell Biol. 1998, 18: 3245-3256.PubMedCentralPubMed Chang BY, Conroy KB, Machleder EM, Cartwright CA: RACK1, a receptor for activated C kinase and a homolog of the beta subunit of G proteins, inhibits activity of src tyrosine kinases and growth of NIH 3T3 cells. Mol Cell Biol. 1998, 18: 3245-3256.PubMedCentralPubMed
31.
go back to reference Liliental J, Chang DD: Rack1, a receptor for activated protein kinase C, interacts with integrin beta subunit. J Biol Chem. 1998, 273: 2379-2383.CrossRefPubMed Liliental J, Chang DD: Rack1, a receptor for activated protein kinase C, interacts with integrin beta subunit. J Biol Chem. 1998, 273: 2379-2383.CrossRefPubMed
32.
go back to reference Lopez-Bergami P, Habelhah H, Bhoumik A, Zhang W, Wang LH, Ronai Z: RACK1 mediates activation of JNK by protein kinase C [corrected]. Mol Cell. 2005, 19: 309-320.PubMedCentralCrossRefPubMed Lopez-Bergami P, Habelhah H, Bhoumik A, Zhang W, Wang LH, Ronai Z: RACK1 mediates activation of JNK by protein kinase C [corrected]. Mol Cell. 2005, 19: 309-320.PubMedCentralCrossRefPubMed
33.
go back to reference Ron D, Kazanietz MG: New insights into the regulation of protein kinase C and novel phorbol ester receptors. Faseb J. 1999, 13: 1658-1676.PubMed Ron D, Kazanietz MG: New insights into the regulation of protein kinase C and novel phorbol ester receptors. Faseb J. 1999, 13: 1658-1676.PubMed
34.
go back to reference Griner EM, Kazanietz MG: Protein kinase C and other diacylglycerol effectors in cancer. Nat Rev Cancer. 2007, 7: 281-294.CrossRefPubMed Griner EM, Kazanietz MG: Protein kinase C and other diacylglycerol effectors in cancer. Nat Rev Cancer. 2007, 7: 281-294.CrossRefPubMed
35.
go back to reference Oka M, Ogita K, Ando H, Kikkawa U, Ichihashi M: Differential down-regulation of protein kinase C subspecies in normal human melanocytes: possible involvement of the zeta subspecies in growth regulation. J Invest Dermatol. 1995, 105: 567-571.CrossRefPubMed Oka M, Ogita K, Ando H, Kikkawa U, Ichihashi M: Differential down-regulation of protein kinase C subspecies in normal human melanocytes: possible involvement of the zeta subspecies in growth regulation. J Invest Dermatol. 1995, 105: 567-571.CrossRefPubMed
36.
go back to reference Gopalakrishna R, Barsky SH: Tumor promoter-induced membrane-bound protein kinase C regulates hematogenous metastasis. Proc Natl Acad Sci USA. 1988, 85: 612-616.PubMedCentralCrossRefPubMed Gopalakrishna R, Barsky SH: Tumor promoter-induced membrane-bound protein kinase C regulates hematogenous metastasis. Proc Natl Acad Sci USA. 1988, 85: 612-616.PubMedCentralCrossRefPubMed
37.
go back to reference Dissanayake SK, Wade MS, Johnson CE, O'Connell MP, Leotlela PD, French AD, Shah KV, Hewitt KJ, Rosenthal DT, Indig FE: The WNT5A/PKC pathway mediates motility in melanoma cells via the inhibition of metastasis suppressors, and initiation of an epithelial to mesenchymal transition. J Biol Chem. 2007 Dissanayake SK, Wade MS, Johnson CE, O'Connell MP, Leotlela PD, French AD, Shah KV, Hewitt KJ, Rosenthal DT, Indig FE: The WNT5A/PKC pathway mediates motility in melanoma cells via the inhibition of metastasis suppressors, and initiation of an epithelial to mesenchymal transition. J Biol Chem. 2007
38.
go back to reference Leotlela PD, Wade MS, Duray PH, Rhode MJ, Brown HF, Rosenthal DT, Dissanayake SK, Earley R, Indig FE, Nickoloff BJ: Claudin-1 overexpression in melanoma is regulated by PKC and contributes to melanoma cell motility. Oncogene. 2007, 26: 3846-3856.CrossRefPubMed Leotlela PD, Wade MS, Duray PH, Rhode MJ, Brown HF, Rosenthal DT, Dissanayake SK, Earley R, Indig FE, Nickoloff BJ: Claudin-1 overexpression in melanoma is regulated by PKC and contributes to melanoma cell motility. Oncogene. 2007, 26: 3846-3856.CrossRefPubMed
39.
go back to reference Gilhooly EM, Morse-Gaudio M, Bianchi L, Reinhart L, Rose DP, Connolly JM, Reed JA, Albino AP: Loss of expression of protein kinase C beta is a common phenomenon in human malignant melanoma: a result of transformation or differentiation?. Melanoma Res. 2001, 11: 355-369.CrossRefPubMed Gilhooly EM, Morse-Gaudio M, Bianchi L, Reinhart L, Rose DP, Connolly JM, Reed JA, Albino AP: Loss of expression of protein kinase C beta is a common phenomenon in human malignant melanoma: a result of transformation or differentiation?. Melanoma Res. 2001, 11: 355-369.CrossRefPubMed
40.
go back to reference Krasagakis K, Fimmel S, Genten D, Eberle J, Quas P, Ziegler W, Haller H, Orfanos CE: Lack of protein kinase C (PKC)-beta and low PKC-alpha, -delta, -epsilon, and -zeta isozyme levels in proliferating human melanoma cells. Int J Oncol. 2002, 20: 865-871.PubMed Krasagakis K, Fimmel S, Genten D, Eberle J, Quas P, Ziegler W, Haller H, Orfanos CE: Lack of protein kinase C (PKC)-beta and low PKC-alpha, -delta, -epsilon, and -zeta isozyme levels in proliferating human melanoma cells. Int J Oncol. 2002, 20: 865-871.PubMed
41.
go back to reference Oka M, Nishigori C, Kageshita T, Hsu MY, Penmatcha S, Herlyn M: Expression of PKC isoforms in human melanocytic cells in situ. J Dermatol Sci. 2006, 41: 157-161.CrossRefPubMed Oka M, Nishigori C, Kageshita T, Hsu MY, Penmatcha S, Herlyn M: Expression of PKC isoforms in human melanocytic cells in situ. J Dermatol Sci. 2006, 41: 157-161.CrossRefPubMed
42.
go back to reference Ron D, Jiang Z, Yao L, Vagts A, Diamond I, Gordon A: Coordinated movement of RACK1 with activated betaIIPKC. J Biol Chem. 1999, 274: 27039-27046.CrossRefPubMed Ron D, Jiang Z, Yao L, Vagts A, Diamond I, Gordon A: Coordinated movement of RACK1 with activated betaIIPKC. J Biol Chem. 1999, 274: 27039-27046.CrossRefPubMed
43.
go back to reference Ron D, Chen CH, Caldwell J, Jamieson L, Orr E, Mochly-Rosen D: Cloning of an intracellular receptor for protein kinase C: a homolog of the beta subunit of G proteins. Proc Natl Acad Sci USA. 1994, 91: 839-843.PubMedCentralCrossRefPubMed Ron D, Chen CH, Caldwell J, Jamieson L, Orr E, Mochly-Rosen D: Cloning of an intracellular receptor for protein kinase C: a homolog of the beta subunit of G proteins. Proc Natl Acad Sci USA. 1994, 91: 839-843.PubMedCentralCrossRefPubMed
44.
go back to reference Nakashima S: Protein kinase C alpha (PKC alpha): regulation and biological function. J Biochem (Tokyo). 2002, 132 (5): 669-675.CrossRef Nakashima S: Protein kinase C alpha (PKC alpha): regulation and biological function. J Biochem (Tokyo). 2002, 132 (5): 669-675.CrossRef
45.
go back to reference Martelli AM, Evangelisti C, Nyakern M, Manzoli FA: Nuclear protein kinase C. Biochim Biophys Acta. 2006, 1761: 542-551.CrossRefPubMed Martelli AM, Evangelisti C, Nyakern M, Manzoli FA: Nuclear protein kinase C. Biochim Biophys Acta. 2006, 1761: 542-551.CrossRefPubMed
46.
go back to reference Saito A, Fujii G, Sato Y, Gotoh M, Sakamoto M, Toda G, Hirohashi S: Detection of genes expressed in primary colon cancers by in situ hybridisation: overexpression of RACK 1. Mol Pathol. 2002, 55: 34-39.PubMedCentralCrossRefPubMed Saito A, Fujii G, Sato Y, Gotoh M, Sakamoto M, Toda G, Hirohashi S: Detection of genes expressed in primary colon cancers by in situ hybridisation: overexpression of RACK 1. Mol Pathol. 2002, 55: 34-39.PubMedCentralCrossRefPubMed
47.
go back to reference Shipitsin M, Campbell LL, Argani P, Weremowicz S, Bloushtain-Qimron N, Yao J, Nikolskaya T, Serebryiskaya T, Beroukhim R, Hu M: Molecular definition of breast tumor heterogeneity. Cancer Cell. 2007, 11: 259-273.CrossRefPubMed Shipitsin M, Campbell LL, Argani P, Weremowicz S, Bloushtain-Qimron N, Yao J, Nikolskaya T, Serebryiskaya T, Beroukhim R, Hu M: Molecular definition of breast tumor heterogeneity. Cancer Cell. 2007, 11: 259-273.CrossRefPubMed
48.
go back to reference McCahill A, Warwicker J, Bolger GB, Houslay MD, Yarwood SJ: The RACK1 scaffold protein: a dynamic cog in cell response mechanisms. Mol Pharmacol. 2002, 62: 1261-1273.CrossRefPubMed McCahill A, Warwicker J, Bolger GB, Houslay MD, Yarwood SJ: The RACK1 scaffold protein: a dynamic cog in cell response mechanisms. Mol Pharmacol. 2002, 62: 1261-1273.CrossRefPubMed
49.
go back to reference Virlon B, Cheval L, Buhler JM, Billon E, Doucet A, Elalouf JM: Serial microanalysis of renal transcriptomes. Proc Natl Acad Sci USA. 1999, 96: 15286-15291.PubMedCentralCrossRefPubMed Virlon B, Cheval L, Buhler JM, Billon E, Doucet A, Elalouf JM: Serial microanalysis of renal transcriptomes. Proc Natl Acad Sci USA. 1999, 96: 15286-15291.PubMedCentralCrossRefPubMed
52.
go back to reference Egidy G, Juillerat-Jeanneret L, Jeannin JF, Korth P, Bosman FT, Pinet F: Modulation of human colon tumor-stromal interactions by the endothelin system. Am J Pathol. 2000, 157: 1863-1874.PubMedCentralCrossRefPubMed Egidy G, Juillerat-Jeanneret L, Jeannin JF, Korth P, Bosman FT, Pinet F: Modulation of human colon tumor-stromal interactions by the endothelin system. Am J Pathol. 2000, 157: 1863-1874.PubMedCentralCrossRefPubMed
53.
go back to reference Johren O, Sanvitto GL, Egidy G, Saavedra JM: Angiotensin II AT1A receptor mRNA expression is induced by estrogen-progesterone in dopaminergic neurons of the female rat arcuate nucleus. J Neurosci. 1997, 17: 8283-8292.PubMed Johren O, Sanvitto GL, Egidy G, Saavedra JM: Angiotensin II AT1A receptor mRNA expression is induced by estrogen-progesterone in dopaminergic neurons of the female rat arcuate nucleus. J Neurosci. 1997, 17: 8283-8292.PubMed
Metadata
Title
Transcription analysis in the MeLiM swine model identifies RACK1 as a potential marker of malignancy for human melanocytic proliferation
Authors
Giorgia Egidy
Sophia Julé
Philippe Bossé
Florence Bernex
Claudine Geffrotin
Silvia Vincent-Naulleau
Vratislav Horak
Xavier Sastre-Garau
Jean-Jacques Panthier
Publication date
01-12-2008
Publisher
BioMed Central
Published in
Molecular Cancer / Issue 1/2008
Electronic ISSN: 1476-4598
DOI
https://doi.org/10.1186/1476-4598-7-34

Other articles of this Issue 1/2008

Molecular Cancer 1/2008 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine